全球多国类风湿关节炎相关间质性肺病的发病率及其与疾病活动度的关联
在5个国家的两个观察性数据库(METEOR、EAC)中评估16,663例类风湿关节炎(RA)患者,描述RA相关间质性肺病(RA-ILD)的患病率与发病率,并探索其与RA疾病活动度的关联。各国RA-ILD患病率存在差异,新诊断RA患者的RA-ILD发病率在荷兰为每1000患者年3.8(95%CI 1.6-9.1)、印度1.6(95%CI 1.0-2.5)、南非6.6(95%CI 2.5-17.5)。DAS28每增加1分对应RA-ILD发生的OR为1.19(95%CI 0.34-4.22),RA-ILD诊断后或匹配时间点后RA-ILD患者的疾病活动度显著高于对照组(β 0.56,95%CI 0.18-0.93)。
要点
- 首次就诊时RA-ILD患病率:荷兰0.09%、印度0.53%、南非1.27%、墨西哥1.42%、哥伦比亚0.62%。
- 新诊断RA患者RA-ILD发病率:荷兰3.8、印度1.6、南非6.6每1000患者年。
- RA-ILD患者疾病活动度显著高于无RA-ILD者(β 0.56,95%CI 0.18-0.93)。
核心结论
- 尽管各国RA-ILD患病率和发病率存在轻微差异,但在来自不同大陆的RA人群中,日常实践中RA-ILD的发病率较低。
- RA-ILD患者的疾病活动度高于无RA-ILD的患者,且更常为ACPA阳性和/或(既往)吸烟者。
研究设计与样本
- 在5个国家中,从两个观察性数据库(METEOR、EAC)收集RA患者的RA-ILD数据,RA-ILD为基于胸部X线或CT的临床诊断。
- 共评估16,663例病程不一的RA患者,并探究随时间变化的疾病活动度与RA-ILD之间可能的关联。
主要发现
- 首次就诊时RA-ILD患病率:荷兰1/1077(0.09%)、印度63/11787(0.53%)、南非8/629(1.27%)、墨西哥6/424(1.42%)、哥伦比亚17/2728(0.62%)。
- 新诊断RA患者RA-ILD发病率:荷兰3.8(95%CI 1.6-9.1)/1000患者年、印度1.6(95%CI 1.0-2.5)/1000患者年、南非6.6(95%CI 2.5-17.5)/1000患者年。
- 随时间DAS28每增加1分,RA-ILD发生的OR为1.19(95%CI 0.34-4.22),未达统计学显著。
- RA-ILD诊断后或匹配时间点后,RA-ILD患者的疾病活动度显著高于对照组(β 0.56,95%CI 0.18-0.93)。
- 两组间DMARD使用无 clear 差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to describe the incidence of RA-ILD in various countries worldwide, and to explore its association with RA disease activity. METHODS: In 5 countries, data on RA-ILD (clinical diagnosis based on chest X-ray or CT) were collected RA patients of two observational databases (METEOR, EAC). We investigated a possible association between disease activity over time and RA-ILD. RESULTS: 16,663 patients with RA with variable disease duration were evaluated. At the first visit recorded in the database, 1/1077 (0.09 %) patients from The Netherlands, 63/11,787 (0.53 %) from India, 8/629 (1.27 %) from South Africa, 6/424 (1.42 %) from Mexico and 17/2728 (0.62 %) from Colombia had an RA-ILD diagnosis. The incidence rate of RA-ILD in patients with newly diagnosed RA was 3.8 (95 % CI 1.6 to 9.1) per 1000 patient years in The Netherlands, 1.6 (95 % CI 1.0 to 2.5) in India and 6.6 (95 % CI 2.5-17.5) in South Africa. The OR for RA-ILD development, per point increase in DAS28 over time was 1.19 (95 % CI 0.34 to 4.22). Disease activity after the RA-ILD diagnosis or a matched timepoint was statistically significantly higher in patients with RA-ILD than in controls (β 0.56 (95 % CI 0.18 to 0.93). There were no clear differences in DMARD use between the two groups. CONCLUSION: Despite slight differences in RA-ILD prevalence and incidence between countries, the incidence of RA-ILD in daily practice is low in our RA population from different continents. Patients with RA-ILD had a higher disease activity than patients without RA-ILD, and were more often ACPA positive and/or (former) smokers.
引用
- Heckert SL, Maarseveen TD, Marges ER, et al. Rheumatoid arthritis-associated interstitial lung disease in countries across the world. Semin Arthritis Rheum. 2025. PMID: 40245586. doi:10.1016/j.semarthrit.2025.152719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。